Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: Results of a pilot study

Investigational New Drugs

Volumn 30, Issue 2, 2012, Pages 688-694

  Cueva, Juan F ^a   Calvo, Marcos ^b   Anido, Urbano ^a   León, Luis ^a   Gallardo, Elena ^a   Areses, Carmen ^a   Bernárdez, Beatriz ^a   Gayoso, Lucía ^a   García, Jorge ^a   Jesús Lamas, María ^a   Curiel, Teresa ^a   Vázquez, Francisca ^a   Candamio, Sonia ^a   Vidal, Yolanda ^a   Javier Barón, Francisco ^a   López, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Asociacion Espanola Contra el Cancer   (Spain)

Author keywords

Asthenia; Breast cancer; Chemotherapy; Docetaxel; Methylphenidate

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; METHYLPHENIDATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; CENTRAL STIMULANT AGENT; TAXOID;

ADJUVANT THERAPY; ADULT; AGED; ANOREXIA; ANXIETY; ARTICLE; ASTHENIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT OF CANCER THERAPY FATIGUE SCALE; HEART PALPITATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SIDE EFFECT; TACHYCARDIA; VISUAL ANALOG SCALE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DAILY LIFE ACTIVITY; FEMALE; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SPAIN; TIME; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTHENIA; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; FEMALE; HUMANS; METHYLPHENIDATE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPAIN; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862248282     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-010-9539-7     Document Type: Article

References (30)

1. NCCN (2010) Nccn clinical practice guidelines in oncologytmcancer-related fatigue: http://www.Nccn.Org/professionals/physician-gls/pdf/fatigue.Pdf.
2. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362(9384):640-650. doi:10.1016/S0140-6736(03)14186-4
3. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23(27):6613-6622. doi:10.1200/JCO.2005.07.024
4. Engels FK, Verweij J (2005) Docetaxel administration schedule: From fever to tears? A review of randomised studies. Eur J Cancer 41(8):1117-1126. doi:10.1016/j.ejca.2005.02.016
5. Gervais R, Ducolone A, Breton JL, Braun D, Lebeau B, Vaylet F, Debieuvre D, Pujol JL, Tredaniel J, Clouet P, Quoix E (2005) Phase ii randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (nsclc). Ann Oncol 16 (1):90-96. doi:10.1093/annonc/mdi018
6. Tabernero J, Climent MA, Lluch A, Albanell J, Vermorken JB, Barnadas A, Anton A, Laurent C, Mayordomo JI, Estaun N, Losa I, Guillem V, Garcia-Conde J, Tisaire JL, Baselga J (2004) A multicentre, randomised phase ii study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 15 (9):1358-1365. doi:10.1093/annonc/mdh349
7. NCCN (2010) Nccn clinical practice guidelines in oncologytmdistress management: http://www.Nccn.Org/professionals/physician-gls/pdf/distress.Pdf.
8. Portenoy RK, Itri LM (1999) Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 4(1):1-10
9. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (fact) measurement system. J Pain Symptom Manage 13(2):63-74.
10. Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (crf). Ann Oncol 20 (1):17-25. doi:10.1093/annonc/mdn537
11. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161 (3):411-420.
12. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (2002) Efficacy and safety of modafinil (provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. J Neurol Neurosurg Psychiatry 72(2):179-183
13. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GP (1992) A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42(8):1468-1471
14. Challman TD, Lipsky JJ (2000) Methylphenidate: Its pharmacology and uses. Mayo Clin Proc 75(7):711-721
15. Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H (2006) Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 119(2):167 e123-130. doi:10.1016/j.amjmed.2005.07.047
16. FDA (2007) Methylphanidate hydrocholire (ritalin® ) - full prescribing information: http://www.Accessdata.Fda.Gov/drugsatfda-docs/label/ 2007/010187s069,018029s040,021284s011lbl.Pdf.
17. Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE (2004) Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 22(23):4795-4803. doi:10.1200/JCO.2004.04.128
18. Fernandez F, Adams F, Holmes VF, Levy JK, Neidhart M (1987) Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants Psychosomatics 28(9):455-461
19. Masand PS, Tesar GE (1996) Use of stimulants in the medically ill. Psychiatr Clin North Am 19(3):515-547
20. Rozans M, Dreisbach A, Lertora JJ, Kahn MJ (2002) Palliative uses of methylphenidate in patients with cancer: A review. J Clin Oncol 20(1):335-339
21. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21(23):4439-4443. doi:10.1200/JCO.2003.06.156JCO.2003.06.156
22. Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis MP (2001) Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am J Hosp Palliat Care 18 (3):187-192
23. Schwartz AL, Thompson JA, Masood N (2002) Interferoninduced fatigue in patients with melanoma: A pilot study of exercise and methylphenidate. Oncol Nurs Forum 29(7):E85-90. doi:10.1188/02.ONF.E85-E90
24. Sood A, Barton DL, Loprinzi CL (2006) Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 23(1):35-40
25. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL (2006) Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24(13):2073-2078. doi:10.1200/JCO.2005.02. 8506
26. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D (2009) Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. J Pain Symptom Manage 38(5):650-662. doi:10.1016/j.jpainsymman. 2009.03.011
27. Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF (2008) A randomised, placebocontrolled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16(6):577-583. doi:10.1007/s00520-007-0341-9
28. Hanna A, Sledge G, Mayer ML, Hanna N, Einhorn L, Monahan P, Daggy J, Bhatia S (2006) A phase ii study of methylphenidate for the treatment of fatigue. Support Care Cancer 14(3):210-215. doi:10.1007/s00520-005-0857-9
29. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 100 (16):1155-1166. doi:10.1093/jnci/djn250
30. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370